Compare EXPE & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | VEEV |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 28.9B |
| IPO Year | 2005 | 2013 |
| Metric | EXPE | VEEV |
|---|---|---|
| Price | $228.14 | $178.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 26 |
| Target Price | $275.37 | ★ $283.80 |
| AVG Volume (30 Days) | ★ 3.4M | 2.0M |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | 9.61 | ★ 34.16 |
| EPS | ★ 9.81 | 3.96 |
| Revenue | ★ $14,733,000,000.00 | $1,104,081,000.00 |
| Revenue This Year | $10.29 | $13.64 |
| Revenue Next Year | $6.97 | $12.67 |
| P/E Ratio | ★ $23.19 | $45.77 |
| Revenue Growth | 7.61 | ★ 28.05 |
| 52 Week Low | $130.01 | $168.14 |
| 52 Week High | $303.80 | $310.50 |
| Indicator | EXPE | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 38.52 |
| Support Level | $227.98 | $169.92 |
| Resistance Level | $229.12 | $184.71 |
| Average True Range (ATR) | 10.34 | 7.38 |
| MACD | 3.45 | 1.11 |
| Stochastic Oscillator | 61.24 | 19.86 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.